7 results
Anticoagulants Common Reversal Agents
 - Warfarin (Coumadin) → Vitamin K (Phytonadione), 4-factor PCC (Kcentra)
 - Heparin/LMWH
Agents - Warfarin ... PCC (Kcentra) - Heparin ... /LMWH → Protamine ... sulfate - Dabigatran ... #noac #pharmacology
Anticoagulant specific factor inhibition. 

#anticoagulation #clotting #INR #heparin #LMWH #NOAC #warfarin #coumadin #rivaroxaban  #Xarelto #apixaban
clotting #INR #heparin ... #LMWH #NOAC #warfarin ... #coumadin #rivaroxaban ... apixaban #Eliquis #dabigatran ... Pradaxa #management #pharmacology
Heparin, Fondaparinux, and Novel Oral Anticoagulants - Pathophysiology

Anticoagulation with parenteral (intravenous or subcutaneous) and oral anticoagulants
the mainstay of VTE ... anticoagulant (e.g. warfarin ... #Pharmacology #Pathophysiology ... #Heparins #LMWH ... #UFH #DOAC #Dabigatran
Summary table of the mechanism of action, side effect and contraindications of commonly used anti-coagulation drugs.
Molecular Weight Heparin ... (LMWH) - Enoxaparin ... - Warfarin - ... ) inhibitors - Dabigatran ... anticoagulation #pharmacology
Oral Anticoagulation Management Cheat Sheet: Warfarin, Apixaban, Dabigatran, Rivaroxaban
 - Mechanism of Action
 - Routine Blood
Management Cheat Sheet: Warfarin ... , Apixaban, Dabigatran ... , Rivaroxaban ... Adjustrnent - Reversal ... Management #Table #Pharmacology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
, edoxaban and rivaroxaban ... anticoagulant; LMWH ... molecular weight heparin ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm
Treatment algorithm for VTE in Malignancy

(A) Suggested treatment algorithm for symptomatic and incidental DVT or PE
§Assess drug-drug ... DOAC, direct oral ... low-molecular-weight heparin ... #DOAC #VTE #Malignancy ... #Cancer #Algorithm